N-cyclobutyl-6-(1H-pyrazolo[4,3-b]pyridin-3-ylamino)-1,2-benzoxazole-3-carboxamide;N-(3-fluorocyclobutyl)-6-(1H-pyrazolo[4,3-b]pyridin-3-ylamino)-1,2-benzoxazole-3-carboxamide;[(3R)-3-methylpyrrolidin-1-yl]-[6-(1H-pyrazolo[4,3-b]pyridin-3-ylamino)-1,2-benzoxazol-3-yl]methanone;N-[3-(trifluoromethyl)-1-benzofuran-6-yl]-2H-pyrazolo[3,4-b]pyridin-3-amine
C70H58F4N22O7 — CID 159524040
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-cyclobutyl-6-(1H-pyrazolo[4,3-b]pyridin-3-ylamino)-1,2-benzoxazole-3-carboxamide;N-(3-fluorocyclobutyl)-6-(1H-pyrazolo[4,3-b]pyridin-3-ylamino)-1,2-benzoxazole-3-carboxamide;[(3R)-3-methylpyrrolidin-1-yl]-[6-(1H-pyrazolo[4,3-b]pyridin-3-ylamino)-1,2-benzoxazol-3-yl]methanone;N-[3-(trifluoromethyl)-1-benzofuran-6-yl]-2H-pyrazolo[3,4-b]pyridin-3-amine
N-cyclobutyl-6-(1H-pyrazolo[4,3-b]pyridin-3-ylamino)-1,2-benzoxazole-3-carboxamide;N-(3-fluorocyclobutyl)-6-(1H-pyrazolo[4,3-b]pyridin-3-ylamino)-1,2-benzoxazole-3-carboxamide;[(3R)-3-methylpyrrolidin-1-yl]-[6-(1H-pyrazolo[4,3-b]pyridin-3-ylamino)-1,2-benzoxazol-3-yl]methanone;N-[3-(trifluoromethyl)-1-benzofuran-6-yl]-2H-pyrazolo[3,4-b]pyridin-3-amine (PubChem CID 159524040) has the molecular formula C70H58F4N22O7 and a molecular weight of 1395.37 g/mol. Its IUPAC name is N-cyclobutyl-6-(1H-pyrazolo[4,3-b]pyridin-3-ylamino)-1,2-benzoxazole-3-carboxamide;N-(3-fluorocyclobutyl)-6-(1H-pyrazolo[4,3-b]pyridin-3-ylamino)-1,2-benzoxazole-3-carboxamide;[(3R)-3-methylpyrrolidin-1-yl]-[6-(1H-pyrazolo[4,3-b]pyridin-3-ylamino)-1,2-benzoxazol-3-yl]methanone;N-[3-(trifluoromethyl)-1-benzofuran-6-yl]-2H-pyrazolo[3,4-b]pyridin-3-amine.
Molecular Properties
| Compound Name | N-cyclobutyl-6-(1H-pyrazolo[4,3-b]pyridin-3-ylamino)-1,2-benzoxazole-3-carboxamide;N-(3-fluorocyclobutyl)-6-(1H-pyrazolo[4,3-b]pyridin-3-ylamino)-1,2-benzoxazole-3-carboxamide;[(3R)-3-methylpyrrolidin-1-yl]-[6-(1H-pyrazolo[4,3-b]pyridin-3-ylamino)-1,2-benzoxazol-3-yl]methanone;N-[3-(trifluoromethyl)-1-benzofuran-6-yl]-2H-pyrazolo[3,4-b]pyridin-3-amine |
|---|---|
| PubChem CID | 159524040 |
| Molecular Formula | C70H58F4N22O7 |
| Molecular Weight | 1395.37 g/mol |
| Exact Mass | 1394.48 |
| IUPAC Name | N-cyclobutyl-6-(1H-pyrazolo[4,3-b]pyridin-3-ylamino)-1,2-benzoxazole-3-carboxamide;N-(3-fluorocyclobutyl)-6-(1H-pyrazolo[4,3-b]pyridin-3-ylamino)-1,2-benzoxazole-3-carboxamide;[(3R)-3-methylpyrrolidin-1-yl]-[6-(1H-pyrazolo[4,3-b]pyridin-3-ylamino)-1,2-benzoxazol-3-yl]methanone;N-[3-(trifluoromethyl)-1-benzofuran-6-yl]-2H-pyrazolo[3,4-b]pyridin-3-amine |
| SMILES | C[C@@H]1CCN(C(=O)c2noc3cc(Nc4n[nH]c5cccnc45)ccc23)C1.FC(F)(F)c1coc2cc(Nc3[nH]nc4ncccc34)ccc12.O=C(NC1CC(F)C1)c1noc2cc(Nc3n[nH]c4cccnc34)ccc12.O=C(NC1CCC1)c1noc2cc(Nc3n[nH]c4cccnc34)ccc12 |
| InChI | InChI=1S/C19H18N6O2.C18H15FN6O2.C18H16N6O2.C15H9F3N4O/c1-11-6-8-25(10-11)19(26)16-13-5-4-12(9-15(13)27-24-16)21-18-17-14(22-23-18)3-2-7-20-17;19-9-6-11(7-9)22-18(26)15-12-4-3-10(8-14(12)27-25-15)21-17-16-13(23-24-17)2-1-5-20-16;25-18(21-10-3-1-4-10)15-12-7-6-11(9-14(12)26-24-15)20-17-16-13(22-23-17)5-2-8-19-16;16-15(17,18)11-7-23-12-6-8(3-4-9(11)12)20-14-10-2-1-5-19-13(10)21-22-14/h2-5,7,9,11H,6,8,10H2,1H3,(H2,21,22,23);1-5,8-9,11H,6-7H2,(H,22,26)(H2,21,23,24);2,5-10H,1,3-4H2,(H,21,25)(H2,20,22,23);1-7H,(H2,19,20,21,22)/t11-;;;/m1.../s1 |
| InChIKey | MCDZAIBREKKKJD-HCEFKKQBSA-N |
| XLogP | 13.99 |
| TPSA | 384.14 Ų |
| H-Bond Donors | 10 |
| H-Bond Acceptors | 22 |
| Rotatable Bonds | 13 |
| Heavy Atoms | 103 |
| Complexity | — |
Lipinski Rule of Five
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 1395.37 |
| LogP ≤ 5 | 13.99 |
| H-Bond Donors ≤ 5 | 10 |
| H-Bond Acceptors ≤ 10 | 22 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 159524040 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.